Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuromuscular
How do you use serum IgG levels to adjust dosing of FcRN inhibitors?
Related to
previous question on dosing of rozanolixizumab
Related Questions
How could you utilize neuromuscular ultrasound as a marker of disease progression/treatment response in CIDP?
How does one interpret an SPEP showing potentially obscured but non-quantifiable M-spike however an IFE showing monoclonal protein?
How do you identify patients with false positive AcHR antibodies?
Should IVIG dosing in patients with autoimmune disease (i.e., dermatomyositis) who become pregnant continue to be based on actual weight at the time of each infusion, or should it be limited to pre-pregnancy weight?
How do you counsel patients with mild congenital myopathy about exercise limitations?
Would you add immunosuppression in ocular myasthenia gravis patients who are symptomatically well-controlled on pyridostigmine?
What is the role of skin biopsy for evaluating small fiber neuropathy in patients with rheumatic disease who have treatment recalcitrant pain?
When do you consider testing autoimmune antibodies for axonal polyneuropathies without clear etiology?
What is the stepwise investigation of patients suspected of inflammatory myopathy?
How do you approach patients with positive LRP4 antibodies without clinical findings of myasthenia gravis?
